MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Acetylcysteine 600mg effervescent tablets (Special Order)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg effervescent tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg effervescent tablets sugar free (Alliance Healthcare (Distribution) Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg effervescent tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg tablets (A A H Pharmaceuticals Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg tablets (Alissa Healthcare Research Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg tablets (Ennogen Healthcare International Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Acetylcysteine 600mg tablets (Medihealth (Northern) Ltd)

Explore other Acetylcysteine formulations Explore other Acetylcysteine 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

AciBic 500mg capsules (MaN Pharma Ltd)

Explore other Sodium bicarbonate formulations Explore other Sodium bicarbonate 500mg capsules suppliers

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Sodium bicarbonate 500mg capsules (Relonchem Ltd).

No Stability Information

AciBic 600mg tablets (MaN Pharma Ltd)

Explore other Sodium bicarbonate formulations Explore other Sodium bicarbonate 600mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Aciclovir 200mg dispersible tablets (A A H Pharmaceuticals Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Incompatible

Aciclovir 200mg dispersible tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Incompatible

Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Incompatible

Aciclovir 200mg dispersible tablets (Medihealth (Northern) Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Incompatible

Aciclovir 200mg dispersible tablets (Phoenix Healthcare Distribution Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Incompatible

Aciclovir 200mg dispersible tablets (Sigma Pharmaceuticals Plc)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Formulation not suitable for use in MCAs. No stability data in MCAs available.

Provenance

This recommendation is based on the products Aciclovir 200mg dispersible tablets (Crescent Pharma Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.